Literature DB >> 25975218

When is facial diplegia regarded as a variant of Guillain-Barré syndrome?

J K Kim1, S Y Oh2, E H Sohn3, Y H Hong4, S M Jun1, J S Bae5.   

Abstract

A variant of Guillain-Barré syndrome (GBS) with predominant manifestation of facial diplegia (FD) has been described recently. This study aimed to characterize and determine the incidence of this FD-predominant GBS variant. The clinical and serological information of 900 consecutive patients were reviewed. In total, eight patients were identified between January 2007 and December 2010 as having FD accompanied by some features of GBS. These features were subjective sensory symptoms such as distal paresthesia (7/8, 88%), albumin-cytological (A/C) dissociation (7/8, 88%), antecedent infection (6/8, 75%), and minor nerve conduction study (NCS) abnormalities (5/7, 71%). One patient presented with the typical NCS feature of demyelinating neuropathy. Only two patients exhibited areflexia (2/8, 25%). None of the patients possessed any anti-ganglioside antibodies; however, the serum of two patients was positive for anti-mycoplasma antibody (2/6, 33%). FD variant of GBS occurred in less than 1% of our dataset. FD can be a regional variant of GBS when it is accompanied by supporting features, such as subjective tingling, A/C dissociation, and minor NCS abnormalities.
© 2015 Peripheral Nerve Society.

Entities:  

Keywords:  Guillain-Barré syndrome (GBS); bilateral; facial paralysis; variant

Mesh:

Substances:

Year:  2015        PMID: 25975218     DOI: 10.1111/jns.12115

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  7 in total

1.  COVID-19-Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barré Syndrome.

Authors:  K L Hutchins; J H Jansen; A D Comer; R V Scheer; G S Zahn; A E Capps; L M Weaver; N A Koontz
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-25       Impact factor: 3.825

2.  Facial diplegia with paresthesia associated with anti-GD1a antibodies.

Authors:  Jason Strawbridge; Katherine A Fu; Joy Chan; William Flavin; Joss Cohen; Inna Keselman; Perry Shieh
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-03-09

3.  Guillain-Barré syndrome variant with facial diplegia and paresthesias after reactivation of varicella zoster virus.

Authors:  Xiaodong Chen; Ying Wang; Yongjun Cao
Journal:  Neurol Sci       Date:  2017-05-16       Impact factor: 3.830

4.  Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody Syndrome.

Authors:  Jong Kuk Kim; Yoo Hwan Kim; Byeol A Yoon; Joong Yang Cho; Sun Young Oh; Ha Young Shin; Ji Soo Kim; Kee Hong Park; Sun Young Kim; Bum Chun Suh; Hung Youl Seok; Jin Hyuk Yoo; Jong Seok Bae
Journal:  J Clin Neurol       Date:  2018-07       Impact factor: 3.077

5.  The Ultimate Poker Face: A Case Report of Facial Diplegia, a Guillain-Barré Variant.

Authors:  Joshua Lowe; James Pfaff
Journal:  Clin Pract Cases Emerg Med       Date:  2020-04-23

6.  Facial Diplegia as a Rare Late Neurologic Manifestation of SARS-CoV-2 Infection.

Authors:  Casey Judge; Negar Moheb; Ramiro Castro Apolo; Joy L Dupont; Michelle L Gessner; Hussam A Yacoub
Journal:  J Neurol Res       Date:  2020-12-09

7.  Bilateral Facial Weakness with Distal Paresthesia Following COVID-19 Vaccination: A Scoping Review for an Atypical Variant of Guillain-Barré Syndrome.

Authors:  Yoo-Hwan Kim; Jee-Eun Kim; Byeol-A Yoon; Jong-Kuk Kim; Jong-Seok Bae
Journal:  Brain Sci       Date:  2022-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.